The nickname "Barbie drug" did not come from a wellness influencer. It came from a 2010 paper in the British Journal of Dermatology, written by researchers who were concerned that people were buying this compound online, injecting it at home, and making decisions about something with a real safety profile based on almost no information. That feels worth knowing before we go any further.
What is the tanning peptide?
Melanotan is the name for a family of lab-made compounds based on a hormone your body already produces called alpha-MSH (alpha-melanocyte-stimulating hormone). Your skin contains cells called melanocytes, and alpha-MSH is the signal that tells them to produce melanin, the dark pigment that causes tanning. Melanotan mimics that signal.
There are two forms. Melanotan I (MT-I) is a close structural copy of the natural hormone. Melanotan II (MT-II) is a shorter, more potent version with a slightly different shape that makes it more metabolically stable and significantly more powerful. Both were developed at the University of Arizona starting in the 1980s. The original research goal was to create a compound that could stimulate skin pigmentation without requiring UV radiation (essentially, a sunless tanning agent). A 1991 trial published in JAMA confirmed the concept worked in humans. The skin darkened. No UV needed.
What is the Barbie peptide?
"Barbie peptide" and "Barbie drug" both refer to Melanotan II. The nickname surfaced in British tabloids and later in peer-reviewed dermatology literature to describe the compound being sold online for cosmetic tanning purposes. The name stuck because the marketing around it leaned heavily on the promise of an effortless golden tan: a very particular aesthetic associated with a very particular doll. It is a catchy name. It is not a safe framing.
Melatonin vs. Melanotan: They Are Not Related
This comes up constantly, so let us be direct: melatonin and melanotan are completely different compounds. They share a root word because both relate to pigmentation-adjacent biology, but that is where the connection ends.
Melatonin is a hormone produced by your pineal gland that regulates your sleep-wake cycle. It is widely available as an over-the-counter supplement, it is considered safe at low doses, and it has nothing to do with skin tanning. Melanotan is a synthetic peptide that activates melanocortin receptors in your skin (and elsewhere in the body). It is a research chemical. It is not sold in supplements. They are not interchangeable, and you cannot find melanotan in a melatonin bottle.
Is it an injection or topical?
Injection. Melanotan has not been studied as a topical skin product and there is no evidence it is absorbed through the skin in any meaningful way. In every human clinical trial, including the JAMA study, it was administered as an injection just under the skin. The pharmaceutical form of the related compound afamelanotide (Scenesse) is administered as a small implant placed just under the skin by a doctor. Nasal spray formulations have been studied in some research settings. Topical melanotan products sold online are not backed by evidence and do not reflect the mechanism by which the compound actually works.
How do researchers use it? A note on research protocols
In the published clinical trials, researchers used small doses of MT-II injected just under the skin over a defined period, with the goal of producing measurable skin pigmentation or studying a specific effect. The 1991 JAMA trial used a melanotropin analog; the 1998 urology crossover trial used MT-II at a single low dose given once. These were controlled settings with medical monitoring, defined endpoints, and safety oversight.
It is worth knowing this because most online content about "dosing" for melanotan does not come from clinical research. It comes from forums where people are experimenting on themselves. Those two things are not the same. The clinical studies provide some data about what effects occurred at what doses under supervised conditions. Forum protocols reflect neither that safety monitoring nor any regulatory oversight.
Is it found in other products?
Yes, in the sense that two FDA-approved pharmaceutical drugs were derived from the same research program. Afamelanotide, sold as Scenesse, is a modified form of MT-I that is FDA-approved as a prescription implant (placed just under the skin) for a rare painful light sensitivity condition called erythropoietic protoporphyria. Bremelanotide, sold as Vyleesi, is derived from MT-II and is FDA-approved as a prescription injection for low sexual desire in premenopausal women (a condition called hypoactive sexual desire disorder).
These are pharmaceutical-grade, prescription-only drugs dispensed by healthcare providers. They are not the same as unregulated Melanotan I or Melanotan II sold as research peptides online.
Is it FDA approved?
The pharmaceutical descendants are. The unregulated research peptides are not.
Scenesse and Vyleesi went through full clinical development, FDA review, and approval for specific medical indications. They are dispensed by prescription for specific patient populations. Melanotan I and Melanotan II as sold online, including any product marketed as a "tanning peptide," are research chemicals. They are not FDA-approved for any use in humans, including cosmetic tanning.
The part that gets left out
Most content about Melanotan focuses on the tan. Here is what the dermatology and toxicology literature documents about unregulated use:
- A 2012 toxicology case report documented severe rhabdomyolysis (dangerous muscle breakdown) and acute kidney damage in someone who overdosed on MT-II. The person required ICU admission.
- A case report in the British Journal of Dermatology documented melanoma development in someone using melanotan, raising concern that stimulating melanocortin receptors may accelerate malignant transformation in susceptible individuals with existing moles.
- Dermatologists have documented rapid and unpredictable changes in pigmented moles in people using unregulated melanotan products. This is considered a significant safety concern. Unexplained mole changes should always be evaluated by a dermatologist.
- MT-II is non-selective: it activates receptors beyond the skin, which is why nausea, facial flushing, spontaneous arousal, and yawning are commonly reported effects alongside the tanning.
This is not a compound with a well-characterized long-term safety profile in the general population. The human clinical trials that exist were small, short-term, and conducted under medical supervision. What happens with repeated use over months or years, or with the dosing patterns common in self-administration contexts, is genuinely unknown.